Sakari Karjalainen
Overview
Explore the profile of Sakari Karjalainen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lindholm O, Karjalainen S, Launis V
Monash Bioeth Rev
. 2025 Feb;
PMID: 40000556
The year 2024 marked the 60th anniversary of the World Medical Association's Declaration of Helsinki (DoH). Coincidentally, the WMA published the 8th revision of this landmark document guiding medical research...
2.
Prades J, Trama A, Casali P, Emile J, Gaspar N, Janavicius R, et al.
Eur J Public Health
. 2022 Nov;
32(6):852-857.
PMID: 36374643
Background: As a system of European Reference Networks (ERNs) emerges, the differences in quality of care for patients with rare cancers may increase at national level. We aimed to elucidate...
3.
Torkki P, Leskela R, Bugge C, Torfadottir J, Karjalainen S
Acta Oncol
. 2022 Sep;
61(10):1216-1222.
PMID: 36151990
Background: High costs of cancer, and especially the increase in treatment costs, have raised concerns about the financial sustainability of publicly funded health care systems around the world. As cancers...
4.
Lawler M, Oliver K, Gijssels S, Aapro M, Abolina A, Albreht T, et al.
J Cancer Policy
. 2022 May;
28:100282.
PMID: 35559911
There are considerable disparities between the quality of cancer care and clinical outcomes for cancer patients in different European countries, regions, hospitals and communities. These have persisted despite the introduction...
5.
Berns A, Ringborg U, Celis J, Heitor M, Aaronson N, Abou-Zeid N, et al.
Mol Oncol
. 2020 Aug;
14(8):1589-1615.
PMID: 32749074
A comprehensive translational cancer research approach focused on personalized and precision medicine, and covering the entire cancer research-care-prevention continuum has the potential to achieve in 2030 a 10-year cancer-specific survival...
6.
Philip T, Karjalainen S, De Lorenzo F, Apostolidis K, Lombardo C, Nilbert M, et al.
Tumori
. 2019 Nov;
105(6):447-455.
PMID: 31718477
The European cancer burden is growing rapidly, with an estimated 2 million deaths a year according to the latest research. As almost half of cancers are diagnosed after the age...
7.
Ortmann O, Helbig U, Torode J, Schreck S, Karjalainen S, Bettio M, et al.
J Cancer Res Clin Oncol
. 2018 Apr;
144(6):1097-1102.
PMID: 29633019
Purpose: National Cancer Control Plans (NCCPs) often describe structural requirements for high quality cancer care. During the fourth European Roundtable Meeting (ERTM) participants shared learnings from their own national setting...
8.
Torkki P, Leskela R, Linna M, Maklin S, Mecklin J, Bono P, et al.
Acta Oncol
. 2018 Feb;
57(7):983-988.
PMID: 29451406
Background: The cost of cancer and outcomes of cancer care have been discussed a lot since cancer represents 3-6% of total healthcare costs and cost estimations have indicated growing costs....
9.
Lawler M, Banks I, Law K, Albreht T, Armand J, Barbacid M, et al.
ESMO Open
. 2017 Aug;
1(6):e000127.
PMID: 28848664
In this implementation phase of the European Cancer Patient's Bill of Rights (BoR), we confirm the following three patient-centred principles that underpin this initiative:The right of every European citizen to...
10.
Torkki P, Leskela R, Linna M, Maklin S, Mecklin J, Bono P, et al.
Acta Oncol
. 2017 Jul;
57(2):297-303.
PMID: 28696797
Introduction: The cost of cancer and outcomes of cancer care has been much debated, since cancer represents 3-6% of total healthcare costs. The objective of this study was to analyse...